Financial Reports 2017

Quarterly Report Q1 2017

Issue link: https://resources.liminalbiosciences.com/i/969612

Contents of this Issue

Navigation

Page 38 of 38

PROMETIC LIFE SCIENCES INC. CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS For the quarter ended on March 31, 2017 (In thousands of Canadian dollars, except for per share amounts) (Unaudited) 38 On April 27, 2017, the Corporation and the holder of the long-term debt entered into an agreement whereby the Corporation received $25,010 in cash in consideration for the issuance of an Original Issue Discount loan having a face value of $39,170 repayable in July 2022 and 10,600,407 warrants with an exercise price of $3.70 per warrant and expiring in October 2023. The Corporation is currently evaluating the accounting for these transactions.

Articles in this issue

view archives of Financial Reports 2017 - Quarterly Report Q1 2017